Skip to main content
. 2021 Aug 16;11:684704. doi: 10.3389/fcimb.2021.684704

Figure 1.

Figure 1

Schematic representation of the experimental design. (A) In PK/PD model, SM buffer (vehicle control) and same dose of purified øKp_Pokalde_002 (phage only control) was administered via both IP and oral route. (B) In Kp56 infection model, bacteria (K. pneumoniae) were administered via IP route only, while treatment (øKp_Pokalde_002) was administered via both IP and oral route. Figure created in BioRender.com. PK, pharmacokinetics; PD, pharmacodynamics; SM, Sodium Magnesium; IP, intraperitoneal.